Literature DB >> 26791389

Operative Trends for Pancreatic Diseases in the USA: Analysis of the Nationwide Inpatient Sample from 1998-2011.

Anwar Dudekula1, Satish Munigala2, Amer H Zureikat3, Dhiraj Yadav4.   

Abstract

The epidemiology of pancreatic diseases is changing. Our aim was to determine the change in indications, frequency, and type of operations being performed for primary pancreatic diseases in the USA. Using the Nationwide Inpatient Sample, all patients aged ≥18 years who underwent pancreatic operations for a primary pancreatic indication between 1998-2011 were identified. Age- and sex-adjusted rates per million adult population were calculated using the 2010 US population as reference. Changes in patient characteristics and outcomes were analyzed. Of 151,454 operations, 82% were resections and 64% were performed for tumors (malignant 52%, benign 12%). Operative rates/million population increased from 41.36 in 1998 to 62.3 in 2011. Population rates increased significantly for distal pancreatectomy, but decreased significantly for drainage procedures (p < 0.05). Additionally, operative rates increased significantly for tumors and cysts/pseudocysts, but decreased significantly for acute pancreatitis (p < 0.05). During this period, mean age, and comorbidity burden for patients undergoing pancreatic operations increased significantly, while their length of hospital stay and in-hospital mortality decreased significantly (p trend <0.05). The number of pancreatic operations performed in the USA is increasing. Although being offered to older patients with more comorbidities, surgeries are being performed with increasing safety and better outcomes.

Entities:  

Keywords:  Cancer; Cystic tumor; Outcome; Pancreas; Pancreatitis; Surgery; Trends

Mesh:

Year:  2016        PMID: 26791389     DOI: 10.1007/s11605-015-3067-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

1.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  Endoscopic therapy for chronic pancreatitis.

Authors:  Rupjyoti Talukdar; D Nageshwar Reddy
Journal:  Curr Opin Gastroenterol       Date:  2014-09       Impact factor: 3.287

Review 3.  The epidemiology of pancreatitis and pancreatic cancer.

Authors:  Dhiraj Yadav; Albert B Lowenfels
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 4.  Surgical treatment of acute pancreatitis.

Authors:  Hein G Gooszen; Marc G H Besselink; Hjalmar C van Santvoort; Thomas L Bollen
Journal:  Langenbecks Arch Surg       Date:  2013-07-16       Impact factor: 3.445

5.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

6.  Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results.

Authors:  P C Freeny; E Hauptmann; S J Althaus; L W Traverso; M Sinanan
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

Review 7.  Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline.

Authors:  J-M Dumonceau; M Delhaye; A Tringali; J E Dominguez-Munoz; J-W Poley; M Arvanitaki; G Costamagna; F Costea; J Devière; P Eisendrath; S Lakhtakia; N Reddy; P Fockens; T Ponchon; M Bruno
Journal:  Endoscopy       Date:  2012-07-02       Impact factor: 10.093

8.  Outcomes of pancreatic debridement in acute pancreatitis: analysis of the nationwide inpatient sample from 1998 to 2010.

Authors:  Blair A Wormer; Ryan Z Swan; Kristopher B Williams; Joel F Bradley; Amanda L Walters; Vedra A Augenstein; John B Martinie; B Todd Heniford
Journal:  Am J Surg       Date:  2014-03-29       Impact factor: 2.565

9.  A comparison of direct endoscopic necrosectomy with transmural endoscopic drainage for the treatment of walled-off pancreatic necrosis.

Authors:  Timothy B Gardner; Prabhleen Chahal; Georgios I Papachristou; Santhi Swaroop Vege; Bret T Petersen; Christopher J Gostout; Mark D Topazian; Naoki Takahashi; Michael G Sarr; Todd H Baron
Journal:  Gastrointest Endosc       Date:  2009-02-24       Impact factor: 9.427

10.  Surgeon volume impacts hospital mortality for pancreatic resection.

Authors:  Robert W Eppsteiner; Nicholas G Csikesz; James T McPhee; Jennifer F Tseng; Shimul A Shah
Journal:  Ann Surg       Date:  2009-04       Impact factor: 12.969

View more
  4 in total

1.  Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer.

Authors:  Faiz Gani; Fabian M Johnston; Howard Nelson-Williams; Marcelo Cerullo; Mary E Dillhoff; Carl R Schmidt; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-06-29       Impact factor: 3.452

2.  Benign Tumors of the Pancreas-Radical Surgery Versus Parenchyma-Sparing Local Resection-the Challenge Facing Surgeons.

Authors:  Hans G Beger
Journal:  J Gastrointest Surg       Date:  2018-01-03       Impact factor: 3.452

3.  Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.

Authors:  M J Passeri; E H Baker; I A Siddiqui; M A Templin; J B Martinie; D Vrochides; D A Iannitti
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

Review 4.  ERAS: Improving outcome in the cachectic HPB patient.

Authors:  David P J van Dijk; Victor van Woerden; Hamit Cakir; Marcel den Dulk; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  J Surg Oncol       Date:  2017-08-02       Impact factor: 3.454

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.